Purified Anti-Human CD134 Antibody(Ber-ACT35)

Target Synonym: IMD;ACT;Tumor necrosis factor receptor superfamily member;Txgp;TNFRSF;TNFRSF4;ACT35;CD134;IMD16;OX40;TXGP1L;ACT35 antigen;OX40L receptor;Recombinant Human OX40/TNFRSF4 Protein (C-Fc);Recombinant Human OX40/TNFRSF4 Protein (C-Fc-Avi);Recombinant Human OX40/TNFRSF4 Protein (C-mFc);Recombinant Human OX40/TNFRSF4 Protein (N-Fc);Tumor necrosis factor receptor superfamily member 4;Txgp1;OX-40; TNFRSF4;Recombinant Human OX40/TNFRSF4 Protein (C-Fc);Recombinant Human OX40/TNFRSF4 Protein (N-Fc)

Background: The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor has been shown to activate NF-kappaB through its interaction with adaptor proteins TRAF2 and TRAF5. Knockout studies in mice suggested that this receptor promotes the expression of apoptosis inhibitors BCL2 and BCL2lL1/BCL2-XL, and thus suppresses apoptosis. The knockout studies also suggested the roles of this receptor in CD4+ T cell response, as well as in T cell-dependent B cell prolifeRation and differentiation.

Immunogen: Recombinant Human CD134 protein

Buffer: PBS, pH 7.2. Contains 0.05% proclin 300.

Dilution: FCM 2 μg/mL(1×10⁵-5×10⁵ cells)

• SKU: ELSE-AB-F1153A-20
• Manufacturer: Elabscience Biotechnology
• Manufacturer SKU: E-AB-F1153A-20
• Package Unit: 50 mg
• Quantity Unit: STK
• Reactivity: Human
• Clonality: Monoclonal
• Application: Flow Cytometry
• Isotype: Mouse IgG1κ
• Host: Mouse
• Conjugate: Unconjugated